Latest News for: mhra
Edit
Regulation as an Enabler of Innovation: A Regional Perspective (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 24 Feb 2026
Edit
The Keene Sentinel
23 Feb 2026
CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC
The Keene Sentinel
23 Feb 2026
Following approval by the European Commission (EC), ...
Edit
Brensocatib licensed as the first medicine specifically designed to treat non-cystic fibrosis bronchiectasis in patients 12 years and older (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 23 Feb 2026
Julian Beach, MHRA Executive Director, Healthcare Quality and Access, said. ... "As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review.".
Edit
MHRA statement on the PATHWAYS puberty blocker trial (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 20 Feb 2026
Edit
Puberty blockers trial paused after MHRA raises safety concerns
BBC News 20 Feb 2026
The medicines regulator is suggesting the minimum age limit for trial should be raised to 14. .
Edit
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
Nasdaq Globe Newswire 20 Feb 2026
Edit
PATHWAYS clinical trial paused following new MHRA advice (UK Department of Health & Social Care)
Public Technologies 20 Feb 2026
The preliminary work in establishing the PATHWAYS clinical trial into the prescription of puberty blockers for children and young people with gender incongruence has been paused, following new concerns raised by the medicines regulator, the MHRA.
Edit
MHRA approves zanidatamab (Ziihera) for the treatment of biliary tract cancer (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 19 Feb 2026
Julian Beach, Interim Executive Director of Healthcare Quality and Access at the MHRA, said. ... "This approval reflects the MHRA's commitment to ensuring patients can access safe and effective medicines where there is an unmet clinical need.
Edit
UK medical device testing hits record high as MHRA backs growth in brain and AI technology (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 19 Feb 2026
At the same time, the MHRA is rolling out new measures to back innovation and remove barriers for smaller companies, including a fee waiver pilot, early market access to promising devices, and enhanced support for high-impact technologies.
Edit
MHRA launches a consultation on indefinite recognition of CE-marked medical devices (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 16 Feb 2026
Lawrence Tallon, Chief Executive at the MHRA said. ... Alongside these measures, the MHRA will continue to strengthen post-market surveillance and work to improve information sharing with EU partners, ensuring patient safety remains paramount.
Edit
Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 16 Feb 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting members of the public to provide their views on proposals for the approach to recognising CE marked medical devices in Great Britain.
Edit
20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 13 Feb 2026
Edit
MHRA introduces additional restrictions for use of the Chikungunya vaccine (IXCHIQ) (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 11 Feb 2026
In February 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the IXCHIQ chikungunya vaccine, see here ... The MHRA is an executive agency of the Department of Health and Social Care.
- 1
- 2
- Next page »